Lee Ainslie Pfizer Inc Transaction History

Maverick Capital LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $977,135 - $1.45 Million	-23,648 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $928,184 - $1.19 Million	23,648 New	23,648 $1.02 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $583,850 - $742,416	-17,444 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $3.73 Million - $4.37 Million	-117,369 Reduced 87.06%	17,444 $640,000
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $3.79 Million - $4.59 Million	125,705 Added 1380.16%	134,813 $4.41 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $246,189 - $351,750	9,108 New	9,108 $297,000
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $5.98 Million - $6.57 Million	-159,570 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $1.75 Million - $1.99 Million	-45,380 Reduced 22.14%	159,570 $6.97 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $7.06 Million - $8.57 Million	204,950 New	204,950 $9.03 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $243 Million - $258 Million	-7,318,410 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $227 Million - $250 Million	7,318,410	7,318,410 $261 Million

3,256

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $140B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.